(GB)
COVID-19 MESSENGER RNA VAKCÍNA (COMIRNATY)(CZ)
COVID-19 MESSENGER RNA VACCINE (COMIRNATY)(RDM)
MRNA VAKCÍNA (MODIFIKOVANÝ NUKLEOSID) (COMIRNATY)(CZ)
VACCINUM COVID-19 MRNA (NUCLEOSIDUM MODIFICATUM) (COMIRNATY)(CZ)
MESSENGER VAKCÍNA COVID-19 (MODIFIKOVANÝ NUKLEOSID) (COMIRNATY)(CZ)
MEDIÁTOROVÁ VAKCÍNA COVID-19 (MODIFIKOVANÝ NUKLEOSID) (COMIRNATY)(CZ)
MESSENGER RNA VAKCÍNA COVID-19 (COMIRNATY)(CZ)
COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) (COMIRNATY)(GB)
COVID-19 MESSENGER VACCINE (NUCLEOSIDE MODIFIED) (COMIRNATY)(GB)
CAS 2417899-77-3(CA)
TOZINAMERAN(INNE)
TOZINAMERAN(INNC)
SINGLE-STRANDED, 5´-CAPPED MESSENGER RNA PRODUCED USING A CELL-FREE IN VITRO TRANSCRIPTION FROM THE CORRESPONDING DNA TEMPLATES, ENCODING THE VIRAL SPIKE (S) PROTEIN OF SARS-COV-2 (COMIRNATY)(SPC)
MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODON-OPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K986P AND V987P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2, GENBANK: MN908947.3) SPIKE (S) GLYCOPROTEIN, FLANKED BY 5' AND 3' UNTRANSLATED REGIONS AND A 3' POLY(A) TAIL; CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M^1PSÍ)(WHO)
JEDNOVLÁKNOVÁ MEDIÁTOROVÁ RNA (MRNA) S ČEPIČKOU NA 5´ KONCI VYRÁBĚNÁ IN VITRO NEBUNĚČNOU TRANSKRIPCÍ Z PŘÍSLUŠNÝCH MATRICÍ DNA A KÓDUJÍCÍ SPIKE (S) PROTEIN VIRU SARS-COV-2 (COMIRNATY)(SPC)
TOZINAMERANUM(INN)